NBBK(NBBK)
NBBK
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E |
|---|---|---|
| Revenue Avg | $300M | $328M |
| Low | $299M | $327M |
| High | $301M | $329M |
| EBITDA Avg | $66M | $72M |
| Low | $65M | $72M |
| High | $66M | $72M |
| EBIT Avg | $62M | $68M |
| Low | $62M | $67M |
| High | $62M | $68M |
| Net Income Avg | $88M | $107M |
| Low | $88M | $107M |
| High | $88M | $108M |
| EPS Avg | $2.13 | $2.60 |
| Low | $2.13 | $2.59 |
| High | $2.14 | $2.62 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $77M | $79M | $78M | $81M | $83M | $85M |
| Low | $77M | $79M | $78M | $81M | $83M | $85M |
| High | $77M | $79M | $78M | $82M | $84M | $86M |
| EBITDA Avg | $17M | $17M | $17M | $18M | $18M | $19M |
| Low | $17M | $17M | $17M | $18M | $18M | $19M |
| High | $17M | $17M | $17M | $18M | $18M | $19M |
| EBIT Avg | $16M | $16M | $16M | $17M | $17M | $18M |
| Low | $16M | $16M | $16M | $17M | $17M | $18M |
| High | $16M | $16M | $16M | $17M | $17M | $18M |
| Net Income Avg | $24M | $26M | $24M | $27M | $28M | $29M |
| Low | $24M | $26M | $24M | $26M | $28M | $29M |
| High | $24M | $26M | $25M | $27M | $28M | $29M |
| EPS Avg | $0.58 | $0.63 | $0.59 | $0.64 | $0.67 | $0.70 |
| Low | $0.58 | $0.62 | $0.59 | $0.64 | $0.67 | $0.70 |
| High | $0.59 | $0.63 | $0.59 | $0.64 | $0.67 | $0.71 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |